X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.430
-0.280 (-7.55%)
Feb 11, 2026, 4:00 PM EST - Market closed
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $299.91 million as of February 12, 2026. Its market cap has increased by 264.99% in one year.
Market Cap
299.91M
Enterprise Value
255.07M
1-Year Change
264.99%
Ranking
Category
Stock Price
$3.43
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $299.91M, an increase of 194.68%. That is a compound annual growth rate of 16.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 299.91M | -14.25% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cybin | 323.87M |
| Century Therapeutics | 321.57M |
| Aldeyra Therapeutics | 320.07M |
| Foghorn Therapeutics | 317.51M |
| Rezolute | 312.49M |
| Candel Therapeutics | 303.59M |
| AC Immune | 299.80M |
| Relmada Therapeutics | 293.33M |